Results 141 to 150 of about 4,313 (158)

Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma

International Journal of Immunopathology and Pharmacology, 2020
Girolamo Pelaia, Pasquale Viola, Corrado Pelaia   +2 more
exaly  

Benralizumab/vedolizumab

Reactions Weekly, 2023
openaire   +1 more source

Reductions in eosinophil biomarkers by benralizumab in patients with asthma

Respiratory Medicine, 2016
Tuyet-Hang Pham, Paul Newbold, Koustubh Ranade   +2 more
exaly  

Benralizumab

Drugs of the Future, 2014
openaire   +1 more source

Eosinophils, the IL-5/IL-5Rα axis, and the biologic effects of benralizumab in severe asthma

Respiratory Medicine, 2019
Enrico Maggi, Andrea Matucci, Alessandra Vultaggio   +2 more
exaly  

Comparative Efficacy and Safety of Dupilumab and Benralizumab in Patients with Inadequately Controlled Asthma: A Systematic Review

International Journal of Molecular Sciences, 2020
Koichi Ando, Hironori Sagara, Akihiko Tanaka   +2 more
exaly  

Benralizumab/mepolizumab

Reactions Weekly, 2022
openaire   +1 more source

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2016
Parameswaran Nair, Eugene R Bleecker, J Mark Fitzgerald   +2 more
exaly  

Benralizumab/ciclosporin

Reactions Weekly, 2021
openaire   +1 more source

Benralizumab

Reactions Weekly, 2019
openaire   +1 more source